Why Is Tuberculosis Making a Comeback?

⬇️ Prefer to listen instead? ⬇️

• TB cases in the U.S. increased by 5% in 2022 compared to pre-pandemic levels.
• The COVID-19 pandemic caused a 20% decline in TB diagnoses, allowing the disease to spread undetected.
• Multidrug-resistant TB cases are rising, making treatment more complicated and costly.
• Individuals with weakened immune systems, such as HIV patients, are at highest risk for developing active TB.
• Increased global travel and migration have contributed to the spread of TB across borders.

Tuberculosis (TB) has been a persistent health threat for centuries, but in recent years, it has made a startling resurgence in the United States and worldwide. Once thought to be largely under control in developed nations, TB is now rising again due to healthcare disruptions, increasing drug-resistant strains, and the lingering impact of the COVID-19 pandemic. Understanding why TB is making a comeback, how it spreads, and its warning signs can help individuals and communities take proactive steps to prevent future tuberculosis outbreaks and manage cases effectively.

Advertisement

A Brief History of Tuberculosis

Tuberculosis is one of the oldest infectious diseases known to humanity, with historical evidence dating as far back as 4,000 years ago. It has been a leading cause of death throughout history, particularly in the 19th and early 20th centuries, when it was often called “consumption” due to the severe weight loss it caused in patients.

Impact of Medical Advancements

In the 1940s and 1950s, the development of antibiotics like streptomycin and isoniazid drastically reduced TB infections, reshaping global public health efforts. Countries with strong healthcare infrastructures saw a sharp decline in cases, leading many to believe TB could be eradicated altogether. However, while TB cases dropped significantly in wealthier nations, the disease never disappeared, especially in low-income regions where medical access, sanitation, and nutrition remained poor.

Why Are Tuberculosis Cases Rising Again?

According to the Centers for Disease Control and Prevention (CDC), TB cases in the U.S. increased by 5% in 2022 compared to pre-pandemic numbers (CDC, 2023). Several crucial factors contribute to this TB resurgence

Healthcare Disruptions from COVID-19

The COVID-19 pandemic had a devastating impact on global TB control efforts. Many healthcare systems prioritized COVID-19 management, delaying routine TB screenings, treatments, and public health initiatives. As a result, TB infections went undiagnosed and untreated, allowing the disease to spread more widely in communities (Pai, Kasaeva, & Swaminathan, 2022).

Rising Multidrug-Resistant TB Strains

One of the most alarming developments in TB resurgence is the increase in drug-resistant TB. Some strains of Mycobacterium tuberculosis have become resistant to first-line antibiotics, making treatment longer, more expensive, and less effective. Drug-resistant TB can require up to two years of treatment with more toxic and costly medications.

Increased Global Travel and Migration

With the return of international travel after the COVID-19 lockdowns, tuberculosis cases have been spreading more rapidly across borders. Immigrants, refugees, and travelers from countries where TB is more common may unknowingly carry latent TB infections, reintroducing the disease into regions that had previously controlled it.

Undiagnosed and Latent TB Cases

An estimated 13 million people in the U.S. have latent TB infections, meaning they carry the bacteria but do not show symptoms. Without proper screening and treatment, roughly 5-10% of these cases will develop into active TB, particularly in individuals with weakened immune systems.

Understanding Tuberculosis Symptoms

Early detection of TB is crucial in preventing transmission and reducing severe health complications. The symptoms of active TB may develop slowly over several weeks or months, making diagnosis difficult.

Common Tuberculosis Symptoms

• Persistent cough (lasting more than three weeks)
• Fever and chills
• Night sweats
• Unexplained weight loss
• Fatigue and weakness

Latent vs. Active Tuberculosis

There are two main types of TB

• Latent TB Infection (LTBI): The bacteria are present in the body but inactive. There are no symptoms, and the person does not spread the disease. However, latent TB can become active when the immune system weakens.
• Active TB Disease: The bacteria multiply, causing noticeable symptoms and making the person infectious.

How Tuberculosis Spreads and Who Is at Risk?

Tuberculosis spreads through the air when an infected person coughs, sneezes, or even speaks in close proximity to others. The disease is not spread by touch, but inhaling TB bacteria can lead to infection.

High-Risk Groups for TB Infection

Certain populations are at higher risk of developing TB, including

• People with weakened immune systems (e.g., HIV/AIDS patients, cancer patients, or those on immunosuppressive medications)
• Healthcare workers who are exposed to TB patients
• People living in crowded or poorly ventilated conditions, such as homeless shelters, prisons, and refugee camps
• Elderly individuals with weakened immunity
• People who travel or immigrate from high-TB-burden countries

Challenges in Diagnosing and Treating TB

TB diagnosis is challenging because its symptoms resemble other respiratory illnesses, such as pneumonia or bronchitis. Doctors use skin tests, blood tests, and chest X-rays to determine infection status.

Issues with TB Treatment

• Strict Medication Adherence: Standard TB treatment lasts six months or more, requiring daily antibiotics. Incomplete treatment can lead to drug-resistant TB.
• Cost and Accessibility: Many low-income patients struggle to afford treatment or reach healthcare facilities.
• Side Effects of TB Drugs: Medications can cause severe liver toxicity, nausea, and neurological issues.

Tuberculosis Treatments: What You Need to Know

Tuberculosis is treatable but requires a long and consistent course of antibiotics to be effective. Common treatments include

• First-line antibiotics: A combination of isoniazid, rifampin, ethambutol, and pyrazinamide for six months.
• Drug-Resistant TB Treatments: More expensive regimens using second-line drugs like bedaquiline and linezolid may be required in multi-drug resistant TB cases.
• Ongoing Research: Scientists are developing shorter, more effective treatments to improve patient compliance and reduce drug resistance.

Preventing Future Tuberculosis Outbreaks

Prevention strategies will be vital in controlling the resurgence of TB. Some key preventive measures include

• Increased TB screening in high-risk populations (e.g., healthcare workers, travelers, and immunocompromised individuals)
• Public health initiatives promoting early detection and treatment adherence
• Improved global access to healthcare in underserved communities
• Continued investment in TB vaccine research and drug development

What Should People Be Aware Of?

Tuberculosis is making a comeback, and early awareness is key to controlling its spread. Contributing factors such as delayed diagnoses, multidrug-resistant strains, and healthcare gaps have made it more difficult to eradicate TB completely. Recognizing tuberculosis symptoms and seeking prompt medical care can help prevent severe complications and protect high-risk communities. Renewed investment in TB prevention and treatment will play a critical role in ensuring that this centuries-old disease does not become a major public health crisis once again.

Citations

• Centers for Disease Control and Prevention. (2023). Tuberculosis in the United States.
• Pai, M., Kasaeva, T., & Swaminathan, S. (2022). COVID-19’s impact on tuberculosis control: Why a renewed focus is needed. The Lancet, 399(10328), 1902-1903.
• World Health Organization. (2023). Tuberculosis fact sheet.